Amlodipine Besylate/Valsartan/Hydrochlorothiazide

苯磺酸氨氯地平/缬沙坦/氢氯噻嗪

Report date: 2025/01/07 11:28:49

Base Information

Drug NameAmlodipine Besylate/Valsartan/Hydrochlorothiazide
Drug Alias NameAmlodipine/Hydrochlorothiazide/Valsartan苯磺酸氨氯地平缬沙坦氢氯噻嗪Amlodipine - valsartan -hydrochlorothiazide mixt缬沙坦苯磺酸氨氯地平氢氯噻嗪Amlodipine Besylate/Hydrochlorothiazide/Valsartan +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitorsVoltage-gated calcium channel blockers
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/04/30
Country/TerritoryUnited StatesEUMainland China
CombinationsYes HydrochlorothiazideAmlodipine BesylateValsartan
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgNovartis Europharm Ltd
Inactive CompaniesYuanhe Pharmaceutical Group Lndustry Co Ltd
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DX01
Related LinksKEGG